FDA Connected to Manufacturer of Deadly Arthritis Drug Actemra
Introduced in 2010, Actemra treats rheumatoid arthritis. Unlike other drugs on the market, it was supposed to not carry the same potentially deadly cardiovascular and lung complications. However, according to a new report from STAT, Actemra is not as safe as FDA and manufacturer, Roche would want consumers to believe. In fact, the STAT report suggests
Read More
Dozens Demand Justice for Exploding Electronic Cigarettes
From 2009 to 2014, the U.S. Fire Administration found 25 media reports of explosion and fire involving electronic cigarettes (e-cigarettes). Without regulation, this number keeps growing. People are demanding justice as dozens file suits against manufacturers in New York, Florida, California and other states. About Electronic Cigarettes Electronic cigarettes are also known as e-cigarettes, e-cigs
Read More
Judge Rules Bayer Could Have Changed Xarelto Label
Before the third Xarelto Bellwether trial began, Bayer and Janssen proposed a motion that they didn’t have the right to change Xarelto’s label. U.S. District Judge Eldon E. Fallon denied their claim, and the third trial will continue as scheduled. Xarelto Bellwether Trial The third trial involves Dora Mingo. While on Xarelto in 2015, she
Read More
Xarelto & Pradaxa Manufacturers Spent Millions Bribing Doctors
Pharmaceutical companies are spending millions of dollars marketing blood-thinners like Xarelto and Pradaxa to doctors. ABC investigation found that manufacturers such as Bayer and Boehringer Ingelheim spend almost $3 million on “educational events” for doctors in a six-month period in 2015. This is troublesome since concerns are mounting that these potentially dangerous medications are being
Read More
Many Receiving Xarelto Overdose
A new study confirms users of the blood thinner Xarelto are on a higher dose than necessary. The higher dose a patient is on the greater the chance for dangerous side effects. The side effects of Xarelto are deadly. About Xarelto Manufactured by Janssen Pharmaceuticals, Xarelto has become a huge financial success. It quickly became the gold standard for the next generation
Read More
Invokana Users Twice as Likely to Experience Amputation
This summer results from two clinical trials prompted the FDA to warn that popular type 2 diabetes medication, Invokana causes an increased risk for leg and foot amputation. Why the Danger Canagliflozin, the active ingredient in Invokana, lowers blood sugar levels in those with type 2 diabetes. It works by increasing the rate of excess
Read More
Deadly Side Effects of Actemra
An independent research group called STAT analyzed a half million adverse reports from patients using the Rheumatoid Arthritis (RA) drugs. They uncovered that over 1,000 people who used Actemra died from heart attacks, stroke, and lung complications. Other RA medications warn of these side effects, but Actemra does not. Actemra & Heart Attacks Just six years after approval,
Read More